Literature DB >> 17304646

Tumor necrosis factor-a inhibition and palmoplantar pustulosis: Janus-faced therapy?

Jan P Dutz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17304646

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

1.  Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in Mice.

Authors:  Lynda Grine; Lien Dejager; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

2.  [First manifestation of psoriasis vulgaris in tumor necrosis factor receptor-associated periodic syndrome during treatment with etanercept].

Authors:  S Boms; T Sehr; U Jappe; A Enk
Journal:  Hautarzt       Date:  2008-08       Impact factor: 0.751

3.  Infliximab can induce a prolonged clinical remission and a decrease in thyroid hormonal requirements in a patient with SAPHO syndrome and hypothyroidism.

Authors:  Francisca Sabugo; Claudio Liberman; Juan Pablo Niedmann; Lilian Soto; Miguel Cuchacovich
Journal:  Clin Rheumatol       Date:  2007-10-16       Impact factor: 2.980
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.